- Home
- MVIS vs BTMD Comparison
MVIS vs BTMD Comparison
Compare MVIS & BTMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MVIS | BTMD |
|---|---|---|
| Founded | 1993 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medicinal Chemicals and Botanical Products |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 284.5M | 80.4M |
| IPO Year | 1996 | N/A |
Fundamental Metrics
Financial Performance| Metric | MVIS | BTMD |
|---|---|---|
| Price | $0.95 | $2.53 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 2 |
| Target Price | $2.50 | ★ $6.00 |
| AVG Volume (30 Days) | ★ 4.6M | 148.1K |
| Earning Date | 11-11-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 270.48 |
| EPS | N/A | ★ 0.78 |
| Revenue | $2,635,000.00 | ★ $195,645,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $859.00 | $2.80 |
| P/E Ratio | ★ N/A | $3.14 |
| Revenue Growth | N/A | ★ 1.34 |
| 52 Week Low | $0.81 | $2.32 |
| 52 Week High | $1.95 | $6.12 |
Technical Indicators
Market Signals| Indicator | MVIS | BTMD |
|---|---|---|
| Relative Strength Index (RSI) | 54.35 | 46.39 |
| Support Level | $0.82 | $2.38 |
| Resistance Level | $0.96 | $2.58 |
| Average True Range (ATR) | 0.05 | 0.14 |
| MACD | 0.01 | -0.02 |
| Stochastic Oscillator | 68.00 | 37.63 |
Price Performance
Historical ComparisonAbout MVIS MicroVision Inc.
Microvision Inc is engaged in developing a lidar sensor to be used in automotive safety and autonomous driving applications. Its lidar sensor uses laser beam scanning (LBS) technology, which is based on systems that include micro-electrical mechanical systems (MEMS), laser diodes, opto-mechanics, electronics, algorithms, and software. The company has also developed solutions for Augmented Reality, Interactive Displays, and Consumer Lidars.
About BTMD Biote Corp.
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company derives revenue from United States and also has its presence in other countries.